5323312023-04-012023-09-305323312023-09-305323312023-04-012023-09-30RelatedPartyTransactionDomain15323312023-03-31RelatedPartyTransactionDomain15323312023-09-30RelatedPartyTransactionDomain15323312023-04-012023-09-30RelatedPartyTransactionDomain25323312023-03-31RelatedPartyTransactionDomain25323312023-09-30RelatedPartyTransactionDomain25323312023-04-012023-09-30RelatedPartyTransactionDomain35323312023-03-31RelatedPartyTransactionDomain35323312023-09-30RelatedPartyTransactionDomain35323312023-04-012023-09-30RelatedPartyTransactionDomain45323312023-03-31RelatedPartyTransactionDomain45323312023-09-30RelatedPartyTransactionDomain45323312023-04-012023-09-30RelatedPartyTransactionDomain55323312023-03-31RelatedPartyTransactionDomain55323312023-09-30RelatedPartyTransactionDomain55323312023-04-012023-09-30RelatedPartyTransactionDomain65323312023-03-31RelatedPartyTransactionDomain65323312023-09-30RelatedPartyTransactionDomain65323312023-04-012023-09-30RelatedPartyTransactionDomain75323312023-03-31RelatedPartyTransactionDomain75323312023-09-30RelatedPartyTransactionDomain75323312023-04-012023-09-30RelatedPartyTransactionDomain85323312023-03-31RelatedPartyTransactionDomain85323312023-09-30RelatedPartyTransactionDomain85323312023-04-012023-09-30RelatedPartyTransactionDomain95323312023-03-31RelatedPartyTransactionDomain95323312023-09-30RelatedPartyTransactionDomain95323312023-04-012023-09-30RelatedPartyTransactionDomain105323312023-03-31RelatedPartyTransactionDomain105323312023-09-30RelatedPartyTransactionDomain105323312023-04-012023-09-30RelatedPartyTransactionDomain115323312023-03-31RelatedPartyTransactionDomain115323312023-09-30RelatedPartyTransactionDomain115323312023-04-012023-09-30RelatedPartyTransactionDomain125323312023-03-31RelatedPartyTransactionDomain125323312023-09-30RelatedPartyTransactionDomain125323312023-04-012023-09-30RelatedPartyTransactionDomain135323312023-03-31RelatedPartyTransactionDomain135323312023-09-30RelatedPartyTransactionDomain135323312023-04-012023-09-30RelatedPartyTransactionDomain145323312023-03-31RelatedPartyTransactionDomain145323312023-09-30RelatedPartyTransactionDomain145323312023-04-012023-09-30RelatedPartyTransactionDomain155323312023-03-31RelatedPartyTransactionDomain155323312023-09-30RelatedPartyTransactionDomain155323312023-04-012023-09-30RelatedPartyTransactionDomain165323312023-03-31RelatedPartyTransactionDomain165323312023-09-30RelatedPartyTransactionDomain165323312023-04-012023-09-30RelatedPartyTransactionDomain175323312023-03-31RelatedPartyTransactionDomain175323312023-09-30RelatedPartyTransactionDomain175323312023-04-012023-09-30RelatedPartyTransactionDomain185323312023-03-31RelatedPartyTransactionDomain185323312023-09-30RelatedPartyTransactionDomain185323312023-04-012023-09-30RelatedPartyTransactionDomain195323312023-03-31RelatedPartyTransactionDomain195323312023-09-30RelatedPartyTransactionDomain195323312023-04-012023-09-30RelatedPartyTransactionDomain205323312023-03-31RelatedPartyTransactionDomain205323312023-09-30RelatedPartyTransactionDomain205323312023-04-012023-09-30RelatedPartyTransactionDomain215323312023-03-31RelatedPartyTransactionDomain215323312023-09-30RelatedPartyTransactionDomain215323312023-04-012023-09-30RelatedPartyTransactionDomain225323312023-03-31RelatedPartyTransactionDomain225323312023-09-30RelatedPartyTransactionDomain225323312023-04-012023-09-30RelatedPartyTransactionDomain235323312023-03-31RelatedPartyTransactionDomain235323312023-09-30RelatedPartyTransactionDomain235323312023-04-012023-09-30RelatedPartyTransactionDomain245323312023-03-31RelatedPartyTransactionDomain245323312023-09-30RelatedPartyTransactionDomain245323312023-04-012023-09-30RelatedPartyTransactionDomain255323312023-03-31RelatedPartyTransactionDomain255323312023-09-30RelatedPartyTransactionDomain255323312023-04-012023-09-30RelatedPartyTransactionDomain265323312023-03-31RelatedPartyTransactionDomain265323312023-09-30RelatedPartyTransactionDomain265323312023-04-012023-09-30RelatedPartyTransactionDomain275323312023-03-31RelatedPartyTransactionDomain275323312023-09-30RelatedPartyTransactionDomain275323312023-04-012023-09-30RelatedPartyTransactionDomain285323312023-03-31RelatedPartyTransactionDomain285323312023-09-30RelatedPartyTransactionDomain285323312023-04-012023-09-30RelatedPartyTransactionDomain295323312023-03-31RelatedPartyTransactionDomain295323312023-09-30RelatedPartyTransactionDomain295323312023-04-012023-09-30RelatedPartyTransactionDomain305323312023-03-31RelatedPartyTransactionDomain305323312023-09-30RelatedPartyTransactionDomain305323312023-04-012023-09-30RelatedPartyTransactionDomain315323312023-03-31RelatedPartyTransactionDomain315323312023-09-30RelatedPartyTransactionDomain315323312023-04-012023-09-30RelatedPartyTransactionDomain325323312023-03-31RelatedPartyTransactionDomain325323312023-09-30RelatedPartyTransactionDomain325323312023-04-012023-09-30RelatedPartyTransactionDomain335323312023-03-31RelatedPartyTransactionDomain335323312023-09-30RelatedPartyTransactionDomain335323312023-04-012023-09-30RelatedPartyTransactionDomain345323312023-03-31RelatedPartyTransactionDomain345323312023-09-30RelatedPartyTransactionDomain345323312023-04-012023-09-30RelatedPartyTransactionDomain355323312023-03-31RelatedPartyTransactionDomain355323312023-09-30RelatedPartyTransactionDomain355323312023-04-012023-09-30RelatedPartyTransactionDomain365323312023-03-31RelatedPartyTransactionDomain365323312023-09-30RelatedPartyTransactionDomain365323312023-04-012023-09-30RelatedPartyTransactionDomain375323312023-03-31RelatedPartyTransactionDomain375323312023-09-30RelatedPartyTransactionDomain375323312023-04-012023-09-30RelatedPartyTransactionDomain385323312023-03-31RelatedPartyTransactionDomain385323312023-09-30RelatedPartyTransactionDomain385323312023-04-012023-09-30RelatedPartyTransactionDomain395323312023-03-31RelatedPartyTransactionDomain395323312023-09-30RelatedPartyTransactionDomain395323312023-04-012023-09-30RelatedPartyTransactionDomain405323312023-03-31RelatedPartyTransactionDomain405323312023-09-30RelatedPartyTransactionDomain405323312023-04-012023-09-30RelatedPartyTransactionDomain415323312023-03-31RelatedPartyTransactionDomain415323312023-09-30RelatedPartyTransactionDomain415323312023-04-012023-09-30RelatedPartyTransactionDomain425323312023-03-31RelatedPartyTransactionDomain425323312023-09-30RelatedPartyTransactionDomain425323312023-04-012023-09-30RelatedPartyTransactionDomain435323312023-03-31RelatedPartyTransactionDomain435323312023-09-30RelatedPartyTransactionDomain435323312023-04-012023-09-30RelatedPartyTransactionDomain445323312023-03-31RelatedPartyTransactionDomain445323312023-09-30RelatedPartyTransactionDomain445323312023-04-012023-09-30RelatedPartyTransactionDomain455323312023-03-31RelatedPartyTransactionDomain455323312023-09-30RelatedPartyTransactionDomain455323312023-04-012023-09-30RelatedPartyTransactionDomain465323312023-03-31RelatedPartyTransactionDomain465323312023-09-30RelatedPartyTransactionDomain465323312023-04-012023-09-30RelatedPartyTransactionDomain475323312023-03-31RelatedPartyTransactionDomain475323312023-09-30RelatedPartyTransactionDomain475323312023-04-012023-09-30RelatedPartyTransactionDomain485323312023-03-31RelatedPartyTransactionDomain485323312023-09-30RelatedPartyTransactionDomain485323312023-04-012023-09-30RelatedPartyTransactionDomain495323312023-03-31RelatedPartyTransactionDomain495323312023-09-30RelatedPartyTransactionDomain495323312023-04-012023-09-30RelatedPartyTransactionDomain505323312023-03-31RelatedPartyTransactionDomain505323312023-09-30RelatedPartyTransactionDomain505323312023-04-012023-09-30RelatedPartyTransactionDomain515323312023-03-31RelatedPartyTransactionDomain515323312023-09-30RelatedPartyTransactionDomain515323312023-04-012023-09-30RelatedPartyTransactionDomain525323312023-03-31RelatedPartyTransactionDomain525323312023-09-30RelatedPartyTransactionDomain525323312023-04-012023-09-30RelatedPartyTransactionDomain535323312023-03-31RelatedPartyTransactionDomain535323312023-09-30RelatedPartyTransactionDomain535323312023-04-012023-09-30RelatedPartyTransactionDomain545323312023-03-31RelatedPartyTransactionDomain545323312023-09-30RelatedPartyTransactionDomain545323312023-04-012023-09-30RelatedPartyTransactionDomain555323312023-03-31RelatedPartyTransactionDomain555323312023-09-30RelatedPartyTransactionDomain555323312023-04-012023-09-30RelatedPartyTransactionDomain565323312023-03-31RelatedPartyTransactionDomain565323312023-09-30RelatedPartyTransactionDomain565323312023-04-012023-09-30RelatedPartyTransactionDomain575323312023-03-31RelatedPartyTransactionDomain575323312023-09-30RelatedPartyTransactionDomain575323312023-04-012023-09-30RelatedPartyTransactionDomain585323312023-03-31RelatedPartyTransactionDomain585323312023-09-30RelatedPartyTransactionDomain585323312023-04-012023-09-30RelatedPartyTransactionDomain595323312023-03-31RelatedPartyTransactionDomain595323312023-09-30RelatedPartyTransactionDomain595323312023-04-012023-09-30RelatedPartyTransactionDomain605323312023-03-31RelatedPartyTransactionDomain605323312023-09-30RelatedPartyTransactionDomain605323312023-04-012023-09-30RelatedPartyTransactionDomain615323312023-03-31RelatedPartyTransactionDomain615323312023-09-30RelatedPartyTransactionDomain615323312023-04-012023-09-30RelatedPartyTransactionDomain625323312023-03-31RelatedPartyTransactionDomain625323312023-09-30RelatedPartyTransactionDomain625323312023-04-012023-09-30RelatedPartyTransactionDomain635323312023-03-31RelatedPartyTransactionDomain635323312023-09-30RelatedPartyTransactionDomain635323312023-04-012023-09-30RelatedPartyTransactionDomain645323312023-03-31RelatedPartyTransactionDomain645323312023-09-30RelatedPartyTransactionDomain645323312023-04-012023-09-30RelatedPartyTransactionDomain655323312023-03-31RelatedPartyTransactionDomain655323312023-09-30RelatedPartyTransactionDomain655323312023-04-012023-09-30RelatedPartyTransactionDomain665323312023-03-31RelatedPartyTransactionDomain665323312023-09-30RelatedPartyTransactionDomain665323312023-04-012023-09-30RelatedPartyTransactionDomain675323312023-03-31RelatedPartyTransactionDomain675323312023-09-30RelatedPartyTransactionDomain675323312023-04-012023-09-30RelatedPartyTransactionDomain685323312023-03-31RelatedPartyTransactionDomain685323312023-09-30RelatedPartyTransactionDomain685323312023-04-012023-09-30RelatedPartyTransactionDomain695323312023-03-31RelatedPartyTransactionDomain695323312023-09-30RelatedPartyTransactionDomain695323312023-04-012023-09-30RelatedPartyTransactionDomain705323312023-03-31RelatedPartyTransactionDomain705323312023-09-30RelatedPartyTransactionDomain705323312023-04-012023-09-30RelatedPartyTransactionDomain715323312023-03-31RelatedPartyTransactionDomain715323312023-09-30RelatedPartyTransactionDomain715323312023-04-012023-09-30RelatedPartyTransactionDomain725323312023-03-31RelatedPartyTransactionDomain725323312023-09-30RelatedPartyTransactionDomain725323312023-04-012023-09-30RelatedPartyTransactionDomain735323312023-03-31RelatedPartyTransactionDomain735323312023-09-30RelatedPartyTransactionDomain735323312023-04-012023-09-30RelatedPartyTransactionDomain745323312023-03-31RelatedPartyTransactionDomain745323312023-09-30RelatedPartyTransactionDomain745323312023-04-012023-09-30RelatedPartyTransactionDomain755323312023-03-31RelatedPartyTransactionDomain755323312023-09-30RelatedPartyTransactionDomain75iso4217:INRAjanta Pharma Limited532331AJANTPHARMNA2023-04-012024-03-31First half yearly2023-04-012023-09-30CrorestruetrueNANAfalsefalseAjanta Pharma LimitedAjanta FoundationCompany is able to exercise significant control over this entityAny other transactionCorporate Social Responsibility expense100000000Transactions are carried out on arms length basis and in ordinary course of business310000000<DIV > <DIV></DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt; LINE-HEIGHT: normal"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ansi-language: EN-US; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN; mso-bidi-theme-font: major-latin; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin'>The Audit Committee has approved CSR Contribution of up to Rs. 10 crores cumulatively for the following entities for the FY 2024: <?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ansi-language: EN-US; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN; mso-bidi-theme-font: major-latin; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin'>1.&nbsp;&nbsp;Samta Puroshattam Agrawal Memorial Foundation<o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ansi-language: EN-US; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN; mso-bidi-theme-font: major-latin; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin'>2.&nbsp; Mamta &amp; Madhusudan Agrawal Memorial Foundation <o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ansi-language: EN-US; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN; mso-bidi-theme-font: major-latin; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin'>3.&nbsp;&nbsp;Seth Bhagwandas Agarwal Charitable Trust<o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ansi-language: EN-US; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN; mso-bidi-theme-font: major-latin; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin'>4.&nbsp; Ajanta Foundation<o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ansi-language: EN-US; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN; mso-bidi-theme-font: major-latin; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin'>5.&nbsp;&nbsp;Manisha Yogesh Agrawal&nbsp;Foundation <o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ansi-language: EN-US; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN; mso-bidi-theme-font: major-latin; mso-ascii-theme-font: major-latin; mso-hansi-theme-font: major-latin'>6.&nbsp;&nbsp;Smriti Rajesh Agrawal Foundation<o:p></o:p></SPAN></P></DIV>Ajanta Pharma LimitedM/s. AI PackagingRelative of ChairmanPurchase of goods or services100000000Transactions are carried out on arms length basis and in ordinary course of business3640000000<DIV > <DIV></DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN lang=EN-US style="mso-ansi-language: EN-US"><FONT face=Calibri>The value of the RPT approved by the Audit Committee is for FY 2024. </FONT><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV>Ajanta Pharma LimitedM/s. AI PackagingRelative of ChairmanAny other transactionTrade PayableN.A.078000003900000Ajanta Pharma LimitedAjanta Pharma (Mauritius) LtdSubsidiarySale of goods or services750000000Transactions are carried out on arms length basis and in ordinary course of business5560000000<DIV > <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN lang=EN-US style="mso-ansi-language: EN-US"><FONT face=Calibri>The value of the RPT approved by the Audit Committee is for FY 2024. </FONT><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <DIV></DIV></DIV>Ajanta Pharma LimitedAjanta Pharma (Mauritius) LtdSubsidiaryAny other transactionTrade ReceivablesN.A.022560000013100000Ajanta Pharma LimitedAjanta Pharma (Mauritius) LtdSubsidiaryAny other transactionTrade PayableN.A.000Ajanta Pharma LimitedAjanta Pharma Limited Group Gratuity TrustCompany is able to exercise significant control over this entityRemunerationN.A.11310000000Ajanta Pharma LimitedAjanta Pharma Nigeria LtdSubsidiaryAny other transactionReimbursement of expensesN.A.60000000Ajanta Pharma LimitedAjanta Pharma Nigeria LtdSubsidiaryAny other transactionAdvance GivenN.A.0400000300000Ajanta Pharma LimitedAjanta Pharma Philippines Inc.SubsidiarySale of goods or services1800000000Transactions are carried out on arms length basis and in ordinary course of business93840000000<DIV > <DIV></DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN lang=EN-US style="mso-ansi-language: EN-US"><FONT face=Calibri>The value of the RPT approved by the Audit Committee is for FY 2024. </FONT><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV>Ajanta Pharma LimitedAjanta Pharma Philippines Inc.SubsidiaryAny other transactionTrade ReceivablesN.A.0433000000751900000Ajanta Pharma LimitedAjanta Pharma Philippines Inc.SubsidiaryInvestmentN.A.01380000013800000Ajanta Pharma LimitedAjanta Pharma USA Inc.SubsidiarySale of goods or services7500000000Transactions are carried out on arms length basis and in ordinary course of business408480000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt"><SPAN lang=EN-US style="mso-ansi-language: EN-US"><FONT face=Calibri>The value of the RPT approved by the Audit Committee is for FY 2024. </FONT><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Ajanta Pharma LimitedAjanta Pharma USA Inc.SubsidiaryAny other transactionOther Income20000000Transactions are carried out on arms length basis and in ordinary course of business670000000<DIV > <DIV></DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt; LINE-HEIGHT: normal"><SPAN lang=EN-US style='FONT-SIZE: 12pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: "Times New Roman"; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'><FONT face=Calibri>The value of the RPT approved by the Audit Committee is for FY 2024. </FONT></SPAN><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV>Ajanta Pharma LimitedAjanta Pharma USA Inc.SubsidiaryAny other transactionTrade ReceivablesN.A.056880000006292200000Ajanta Pharma LimitedAjanta Pharma USA Inc.SubsidiaryAny other transactionOther ReceivablesN.A.062000003300000Ajanta Pharma LimitedAjanta Pharma USA Inc.SubsidiaryInvestmentN.A.07070000070700000Ajanta Pharma LimitedArvind AgrawalChief Financial Officer & KMPRemunerationN.A.920000000Ajanta Pharma LimitedArvind AgrawalChief Financial Officer & KMPRemunerationN.A.10000000Ajanta Pharma LimitedChandrakant M. KhetanIndependent DirectorAny other transactionSitting fees paidN.A.40000000Ajanta Pharma LimitedChandrakant M. KhetanIndependent DirectorAny other transactionCommission to DirectorsN.A.20000000Ajanta Pharma LimitedChandrakant M. KhetanIndependent DirectorAny other transactionCommission payableN.A.0400000200000Ajanta Pharma LimitedDr. Anjana GrewalIndependent DirectorAny other transactionSitting fees paidN.A.30000000Ajanta Pharma LimitedDr. Anjana GrewalIndependent DirectorAny other transactionCommission to DirectorsN.A.10000000Ajanta Pharma LimitedDr. Anjana GrewalIndependent DirectorAny other transactionCommission payableN.A.0300000100000Ajanta Pharma LimitedGaurang ShahCompany Secretary & KMPRemunerationN.A.490000000Ajanta Pharma LimitedGaurang ShahCompany Secretary & KMPRemunerationN.A.30000000Ajanta Pharma LimitedK. H. ViswanathanIndependent DirectorAny other transactionSitting fees paidN.A.40000000Ajanta Pharma LimitedK. H. ViswanathanIndependent DirectorAny other transactionCommission to DirectorsN.A.10000000Ajanta Pharma LimitedK. H. ViswanathanIndependent DirectorAny other transactionCommission payableN.A.0300000100000Ajanta Pharma LimitedMadhusudan B. AgrawalExecutive Vice-ChairmanRemunerationN.A.2100000000Ajanta Pharma LimitedMadhusudan B. AgrawalExecutive Vice-ChairmanRemunerationN.A.150000000Ajanta Pharma LimitedMamta and Madhusudan Agrawal Memorial FoundationPromoter group is able to exercise significant control over this entityAny other transactionCorporate Social Responsibility expense100000000Transactions are carried out on arms length basis and in ordinary course of business3500000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt; LINE-HEIGHT: normal"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>The Audit Committee has approved CSR Contribution of up to Rs. 10 crores cumulatively for the following entities for the FY 2024: <?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>1.&nbsp;&nbsp;Samta Puroshattam Agrawal Memorial Foundation<o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>2.&nbsp; Mamta &amp; Madhusudan Agrawal Memorial Foundation <o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>3.&nbsp;&nbsp;Seth Bhagwandas Agarwal Charitable Trust<o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>4.&nbsp; Ajanta Foundation<o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>5.&nbsp;&nbsp;Manisha Yogesh Agrawal&nbsp;Foundation <o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>6.&nbsp;&nbsp;Smriti Rajesh Agrawal Foundation<o:p></o:p></SPAN></P></DIV></DIV>Ajanta Pharma LimitedMannalal B. AgrawalNon Executive Director - ChairmanAny other transactionSitting fees paidN.A.40000000Ajanta Pharma LimitedPrabhakar DalalIndependent DirectorAny other transactionSitting fees paidN.A.30000000Ajanta Pharma LimitedPrabhakar DalalIndependent DirectorAny other transactionCommission to DirectorsN.A.10000000Ajanta Pharma LimitedPrabhakar DalalIndependent DirectorAny other transactionCommission payableN.A.0300000100000Ajanta Pharma LimitedRajesh M. AgrawalJoint Managing Director & KMPRemunerationN.A.6800000000Ajanta Pharma LimitedRajesh M. AgrawalJoint Managing Director & KMPRemunerationN.A.110000000Ajanta Pharma LimitedRajesh M. AgrawalJoint Managing Director & KMPAny other transactionCommission to DirectorsN.A.3000000000Ajanta Pharma LimitedRajesh M. AgrawalJoint Managing Director & KMPAny other transactionCommission payableN.A.03300000030000000Ajanta Pharma LimitedSeth Bhagwandas Agarwal Charitable TrustPromoter group is able to exercise significant control over this entityAny other transactionCorporate Social Responsibility expense100000000Transactions are carried out on arms length basis and in ordinary course of business000<DIV > <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt; LINE-HEIGHT: normal"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>The Audit Committee has approved CSR Contribution of up to Rs. 10 crores cumulatively for the following entities for the FY 2024: <?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>1.&nbsp;&nbsp;Samta Puroshattam Agrawal Memorial Foundation<o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>2.&nbsp; Mamta &amp; Madhusudan Agrawal Memorial Foundation <o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>3.&nbsp;&nbsp;Seth Bhagwandas Agarwal Charitable Trust<o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>4.&nbsp; Ajanta Foundation<o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>5.&nbsp;&nbsp;Manisha Yogesh Agrawal&nbsp;Foundation <o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>6.&nbsp;&nbsp;Smriti Rajesh Agrawal Foundation<o:p></o:p></SPAN></P> <DIV></DIV></DIV>Ajanta Pharma LimitedTanya AgrawalDaughter of Managing DirectorRemuneration1000000Transactions are carried out on arms length basis and in ordinary course of business60000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt; LINE-HEIGHT: normal"><SPAN lang=EN-US style='FONT-SIZE: 12pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: "Times New Roman"; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'><FONT face=Calibri>The value of the RPT approved by the Audit Committee is for FY 2024. </FONT></SPAN><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Ajanta Pharma LimitedTanya AgrawalDaughter of Managing DirectorRemunerationN.A.10000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt; LINE-HEIGHT: normal"><SPAN lang=EN-US style='FONT-SIZE: 12pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: "Times New Roman"; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'><FONT face=Calibri>.</FONT></SPAN></P></DIV></DIV>Ajanta Pharma LimitedYogesh M. AgrawalManaging Director & KMPRemunerationN.A.6800000000Ajanta Pharma LimitedYogesh M. AgrawalManaging Director & KMPRemunerationN.A.120000000Ajanta Pharma LimitedYogesh M. AgrawalManaging Director & KMPAny other transactionCommission to DirectorsN.A.3000000000Ajanta Pharma LimitedYogesh M. AgrawalManaging Director & KMPAny other transactionCommission payableN.A.03300000030000000Ajanta Pharma LimitedAjanta Pharma (Mauritius) LtdSubsidiaryInvestmentN.A.09440000094400000Ajanta Pharma LimitedAjanta Pharma Philippines Inc.SubsidiaryDividend receivedN.A.29130000000Ajanta Pharma LimitedSamta Puroshattam Agrawal Memorial FoundationPromoter group is able to exercise significant control over this entityAny other transactionCorporate Social Responsibility expense100000000Transactions are carried out on arms length basis and in ordinary course of business5350000000<DIV > <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt; LINE-HEIGHT: normal"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>The Audit Committee has approved CSR Contribution of up to Rs. 10 crores cumulatively for the following entities for the FY 2024: <?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>1.&nbsp;&nbsp;Samta Puroshattam Agrawal Memorial Foundation<o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>2.&nbsp; Mamta &amp; Madhusudan Agrawal Memorial Foundation <o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>3.&nbsp;&nbsp;Seth Bhagwandas Agarwal Charitable Trust<o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>4.&nbsp; Ajanta Foundation<o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>5.&nbsp;&nbsp;Manisha Yogesh Agrawal&nbsp;Foundation <o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>6.&nbsp;&nbsp;Smriti Rajesh Agrawal Foundation<o:p></o:p></SPAN></P> <DIV></DIV></DIV>Ajanta Pharma LimitedYash AgrawalSon of Managing DirectorRemuneration600000Transactions are carried out on arms length basis and in ordinary course of business10000000<DIV > <DIV></DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt; LINE-HEIGHT: normal"><SPAN lang=EN-US style='FONT-SIZE: 12pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: "Times New Roman"; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'><FONT face=Calibri>The value of the RPT approved by the Audit Committee is for FY 2024. </FONT></SPAN><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV>Ajanta Pharma LimitedYash AgrawalSon of Managing DirectorRemunerationN.A.000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt; LINE-HEIGHT: normal"><SPAN lang=EN-US style='FONT-SIZE: 12pt; mso-ascii-font-family: Calibri; mso-fareast-font-family: "Times New Roman"; mso-hansi-font-family: Calibri; mso-bidi-font-family: Calibri; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'><FONT face=Calibri>. </FONT></SPAN><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Times New Roman",serif; mso-fareast-font-family: "Times New Roman"; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'><?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P></DIV></DIV>Ajanta Pharma LimitedManisha Yogesh Agrawal FoundationPromoter group is able to exercise significant control over this entityAny other transactionCorporate Social Responsibility expense100000000Transactions are carried out on arms length basis and in ordinary course of business750000000<DIV > <DIV> <P class=MsoNormal style="MARGIN: 0cm 0cm 8pt; LINE-HEIGHT: normal"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>The Audit Committee has approved CSR Contribution of up to Rs. 10 crores cumulatively for the following entities for the FY 2024: <?xml:namespace prefix = "o" ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>1.&nbsp;&nbsp;Samta Puroshattam Agrawal Memorial Foundation<o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>2.&nbsp; Mamta &amp; Madhusudan Agrawal Memorial Foundation <o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>3.&nbsp;&nbsp;Seth Bhagwandas Agarwal Charitable Trust<o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>4.&nbsp; Ajanta Foundation<o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>5.&nbsp;&nbsp;Manisha Yogesh Agrawal&nbsp;Foundation <o:p></o:p></SPAN></P> <P class=MsoNormalCxSpMiddle style="MARGIN: 0cm 0cm 0pt 14.2pt; LINE-HEIGHT: normal; TEXT-INDENT: -14.2pt; mso-add-space: auto"><SPAN lang=EN-US style='FONT-SIZE: 12pt; FONT-FAMILY: "Calibri Light",sans-serif; mso-ascii-theme-font: major-latin; mso-fareast-font-family: "Times New Roman"; mso-hansi-theme-font: major-latin; mso-bidi-theme-font: major-latin; mso-ansi-language: EN-US; mso-fareast-language: EN-IN'>6.&nbsp;&nbsp;Smriti Rajesh Agrawal Foundation<o:p></o:p></SPAN></P></DIV></DIV>Ajanta Pharma LimitedYogesh M Agrawal, trustee Yogesh Agrawal Trust PromoterDividend paidN.A.45580000000Ajanta Pharma LimitedRajesh M Agrawal, trustee Rajesh Agrawal Trust PromoterDividend paidN.A.45580000000Ajanta Pharma LimitedRavi P Agrawal, trustee Ravi Agrawal TrustPromoterDividend paidN.A.40970000000Ajanta Pharma LimitedRavi P AgrawalPromoterDividend paidN.A.710000000Ajanta Pharma LimitedGanga Exports being represented by Yogesh Agrawal, Rajesh Agrawal & Ravi AgrawalPromoterDividend paidN.A.8450000000Ajanta Pharma LimitedGabs Investments Pvt Ltd PromoterDividend paidN.A.31470000000Ajanta Pharma LimitedArvind AgrawalChief Financial Officer & KMPDividend paidN.A.90000000Ajanta Pharma LimitedGaurang ShahCompany Secretary & KMPDividend paidN.A.4000000Ajanta Pharma LimitedChandrakant KhetanIndependent DirectorDividend paidN.A.3000000Ajanta Pharma LimitedAayush M Agrawal, trustee Aayush Agrawal TrustPromoterDividend paidN.A.35590000000Ajanta Pharma LimitedAayush M Agrawal PromoterDividend paidN.A.80000000Ajanta Pharma LimitedYogesh M Agrawal, trustee Yogesh Agrawal Trust PromoterAny other transactionBuyback of Equity SharesN.A.04807000000Ajanta Pharma LimitedRajesh M Agrawal, trustee Rajesh Agrawal Trust PromoterAny other transactionBuyback of Equity SharesN.A.04807000000Ajanta Pharma LimitedRavi P Agrawal, trustee Ravi Agrawal TrustPromoterAny other transactionBuyback of Equity SharesN.A.04328000000Ajanta Pharma LimitedAayush M Agrawal, trustee Aayush Agrawal TrustPromoterAny other transactionBuyback of Equity SharesN.A.03934000000Ajanta Pharma LimitedGanga Exports being represented by Yogesh Agrawal, Rajesh Agrawal & Ravi AgrawalPromoterAny other transactionBuyback of Equity SharesN.A.01004000000Ajanta Pharma LimitedArvind AgrawalChief Financial Officer & KMPAny other transactionBuyback of Equity SharesN.A.011000000Ajanta Pharma LimitedGaurang ShahCompany Secretary & KMPAny other transactionBuyback of Equity SharesN.A.0500000Ajanta Pharma LimitedChandrakant KhetanIndependent DirectorAny other transactionBuyback of Equity SharesN.A.0200000Ajanta Pharma LimitedAjanta Pharma Nigeria LtdSubsidiaryInvestmentN.A.01370000013700000Ajanta Pharma LimitedAjanta Pharma Nigeria LtdSubsidiaryAny other transactionImpairment of Investment in SubsidiaryN.A.01370000013700000